| REVIEW ARTICLE |
|
| Year : 2014 | Volume
: 1
| Issue : 2 | Page : 81-86 |
|
|
Prevention of ovarian hyperstimulation syndrome
Raj Mathur
Department of Reproductive Medicine, St Mary's Hospital, Central Manchester NHS Foundation Trust, Manchester, United Kingdom
Correspondence Address:
Dr. Raj Mathur
St Mary's Hospital, Central Manchester NHS Foundation Trust, Oxford Road, Manchester, M13 9WL
United Kingdom
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2394-4285.162777
|
|
|
Ovarian hyperstimulation syndrome (OHSS) is a potentially serious complication of ovarian stimulation for fertility treatment. Risk factors include polycystic ovaries, high ovarian reserve, and excessive ovarian response to stimulation. It is important to be aware of the risk of OHSS, even in so called "low-risk" situations. An understanding of the pathophysiology of OHSS may help clinicians to target preventative measures in women who are at risk. Ovarian stimulation regimes based on an individualized reserve assessment may help reduce the incidence of OHSS. Gonadotropin-releasing hormone (GnRH) antagonist regimes are associated with a lower risk than GnRH agonist regimes and the risk may be further reduced if a GnRH agonist trigger is used in place of human chorionic gonadotropin (hCG). Other methods of reducing hCG exposure include avoiding hCG luteal support, cryopreservation of all embryos, and avoidance of multiple pregnancy. However, the only method that guarantees avoidance of OHSS in high-response cycles is cycle cancellation. Clinicians should be aware of the potential value of coasting and dopamine agonists, as measures to reduce risk in the presence of an excessive ovarian response. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
